Search - tctmd.com

Displaying 141 - 160 of 179

Sort: Relevancy | Date

Presentation TCT 2015

Transcatheter Mitral Therapies in 2015: MitraClip in Trials and the Real World

Presenter: Blase A. Carabello, Howard C. Herrmann, Ted E. Feldman

October 12, 2015

Presentation TCT 2015

What Will TAVR Look Like in 2 and 10 Years From Now?

Presenter: Blase A. Carabello, Howard C. Herrmann, Duane S. Pinto

October 12, 2015

Presentation TCT 2015

TAVR 2015: Current Status

Presenter: Blase A. Carabello, Howard C. Herrmann, James B. Hermiller Jr

October 12, 2015

Presentation TCT 2015

Guideline Update: Whats New, and Whats Left Unsaid?

Presenter: Blase A. Carabello, Howard C. Herrmann

October 12, 2015

Presentation TCT 2015

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Presenter: Zoltan G. Turi, Rahul Sakhuja

October 12, 2015

Presentation TCT 2015

Valvular Heart Disease: Treatment of Mitral Stenosis and Mitral Regurgitation

Presenter: Michael J. Lim, Molly Szerlip

October 12, 2015

News Conference News TCT 2015

Symposia Highlights Variances Between Guideline-Based, ‘Real-World’ Indications for TAVR

October 11, 2015

News Features TCT 2014

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Todd Neale

October 24, 2014

Presentation TCT 2014

MitraClip: Current Application and Future Directions

Presenter: Blase A. Carabello, George D. Dangas, Michael J. Rinaldi

September 15, 2014

Presentation TCT 2014

Controversies in Aortic Valve Disease: Challenging Clinical Scenarios (Asymptomatic AS, Low-Flow Low-Gradient AS, and Concomitant CAD)

Presenter: Blase A. Carabello, George D. Dangas

September 15, 2014

Presentation TCT 2014

TAVR On the Horizon: Emerging TAVR Platforms and Technologies

Presenter: Blase A. Carabello, George D. Dangas, Lutz Buellesfeld

September 15, 2014

Presentation TCT 2014

TAVR Update: FDA-Approved Valve Systems

Presenter: Blase A. Carabello, George D. Dangas, Alan C. Yeung

September 15, 2014

Presentation TCT 2014

Guideline Update: Aortic and Mitral Valve Disease and the 2014 AHA/ACC Guideline for Valvular Heart Disease

Presenter: Blase A. Carabello, George D. Dangas, Patrick T. O'Gara

September 15, 2014

Presentation TCT 2014

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Presenter: Zoltan G. Turi, Jason Kovacic

September 14, 2014

Presentation TCT 2014

Valvular Heart Disease: Treatment of Mitral Stenosis and Mitral Regurgitation

Presenter: Michael J. Lim, Hemal Gada

September 14, 2014

News Conference News TCT 2014

PARTNER: Post-TAVR Survival Higher in Overweight, Obese Patients

September 14, 2014

News Conference News TCT 2014

Michael J. Mack, MD, Becomes First Surgeon to Receive TCT Career Achievement Award

September 13, 2014

Presentation TCT 2014

Valvular Heart Disease for the Interventionalist

Presenter: Greg L. Kaluza, Manish A. Parikh, Varinder P. Singh, Nicola Corvaja

September 12, 2014

Presentation TCT 2013

Valvular Heart Disease: Best of EHJ

Presenter: Stephan Windecker

October 30, 2013

Presentation TCT 2013

Treatment Strategies in Patients with Atrial Fibrillation and Valvular Heart Disease

Presenter: Ted Feldman

October 29, 2013

Advertisement

Transcatheter Mitral Therapies in 2015: MitraClip in Trials and the Real World

What Will TAVR Look Like in 2 and 10 Years From Now?

TAVR 2015: Current Status

Guideline Update: Whats New, and Whats Left Unsaid?

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Valvular Heart Disease: Treatment of Mitral Stenosis and Mitral Regurgitation

Symposia Highlights Variances Between Guideline-Based, ‘Real-World’ Indications for TAVR

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

MitraClip: Current Application and Future Directions

Controversies in Aortic Valve Disease: Challenging Clinical Scenarios (Asymptomatic AS, Low-Flow Low-Gradient AS, and Concomitant CAD)

TAVR On the Horizon: Emerging TAVR Platforms and Technologies

TAVR Update: FDA-Approved Valve Systems

Guideline Update: Aortic and Mitral Valve Disease and the 2014 AHA/ACC Guideline for Valvular Heart Disease

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Valvular Heart Disease: Treatment of Mitral Stenosis and Mitral Regurgitation

PARTNER: Post-TAVR Survival Higher in Overweight, Obese Patients

Michael J. Mack, MD, Becomes First Surgeon to Receive TCT Career Achievement Award

Valvular Heart Disease for the Interventionalist

Valvular Heart Disease: Best of EHJ

Treatment Strategies in Patients with Atrial Fibrillation and Valvular Heart Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content